文献速递眼底病与葡萄膜炎

镰状细胞病视网膜病变患者黄斑神经退行性与血管异常在光学相干断层扫描血管成像上的纵向变化

LONGITUDINAL CHANGES OF MACULAR NEURODEGENERATIVE AND VASCULAR ABNORMALITIES ON OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN SICKLE CELL DISEASE.
PubMed 文献 · Retina · 2025-01-02

研究纳入60例镰状细胞病患者的106只眼,用光学相干断层扫描及血管成像随访中位34.5个月,发现黄斑变薄从基线41眼(38.7%)增至随访52眼(49.1%),25.5%(27/106)患眼黄斑变薄进展,15.1%(16/106)患眼镰状细胞视网膜病变进展。黄斑变薄进展的预测因素包括增殖性视网膜病变(校正OR 3.40,P=0.024)、下旁凹亚区颞上毛细血管丛较低血管密度(校正OR 0.88,P=0.003)和下旁凹亚区深毛细血管丛较高血管密度(校正OR 1.17,P=0.001)。

要点

  • 黄斑变薄在基线占38.7%(41/106眼),随访增至49.1%(52/106眼),25.5%(27/106)患眼出现进展。
  • 增殖性视网膜病变(校正OR 3.40,P=0.024)与黄斑变薄进展相关。
  • 下旁凹亚区颞上毛细血管丛血管密度较低(校正OR 0.88,P=0.003)及深毛细血管丛血管密度较高(校正OR 1.17,P=0.001)与黄斑变薄进展相关。

核心结论

  • 镰状细胞病相关黄斑病变在短期随访中于许多患者中进展,但未损害视力。
  • 黄斑病变进展与增殖性视网膜病变及下旁凹亚区血管密度相关。
  • 需要进一步研究以阐明黄斑变化的功能后果。

研究设计与样本

  • 对连续镰状细胞病患者(HbSS/HbSβ0/HbSβ+/HbSC基因型)在基线和随访时进行完整眼科检查,包括眼底镜检查和黄斑谱域光学相干断层扫描/光学相干断层扫描血管成像。
  • 镰状细胞视网膜病变分期基于眼底镜检查而非Goldberg分类,因荧光素血管造影未常规使用。
  • 从医疗记录中获取内科/眼科病史和血液学特征。
  • 分析106只眼(60例患者),中位随访34.5个月(范围8-70,四分位距25-55)。

主要发现

  • 基线时黄斑变薄存在于41眼(38.7%),随访时存在于52眼(49.1%)。
  • 黄斑变薄进展见于25.5%(27/106)的患眼,镰状细胞视网膜病变进展见于15.1%(16/106)的患眼。
  • 黄斑变薄进展的预测因素为增殖性视网膜病变(校正OR 3.40,P=0.024)、下旁凹亚区颞上毛细血管丛较低血管密度(校正OR 0.88,P=0.003)和下旁凹亚区深毛细血管丛较高血管密度(校正OR 1.17,P=0.001)。
  • 未发现黄斑变薄进展与其他器官损害恶化、镰状细胞视网膜病变进展、眼部并发症或激光治疗之间存在关联。

关键数值与推荐

  • 黄斑变薄进展的预测因素:增殖性视网膜病变校正OR 3.40(P=0.024)。
  • 下旁凹亚区颞上毛细血管丛血管密度校正OR 0.88(P=0.003)。
  • 下旁凹亚区深毛细血管丛血管密度校正OR 1.17(P=0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需要进一步研究以阐明黄斑变化的功能后果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the presence and progression of maculopathy in patients with sickle cell disease using optical coherence tomography and optical coherence tomography-angiography and to identify clinical/laboratory risk factors for progression during follow-up. METHODS: Complete ophthalmic examination, including fundoscopy and macular spectral-domain-optical coherence tomography/optical coherence tomography angiography scans, was performed in consecutive patients with sickle cell disease (HbSS/HbSβ 0 /HbSβ + /HbSC genotype) during baseline and follow-up visits. Sickle cell retinopathy stage was based on fundoscopy instead of the Goldberg classification, as fluorescein angiography was not routinely used. Medical/ophthalmological history and hematologic characteristics were retrieved from medical records. RESULTS: One hundred and six eyes of 60 patients were analyzed. The median follow-up period was 34.5 months (range 8-70, interquartile range 25-55). Macular thinning was present in 41 eyes (38.7%) at baseline and in 52 eyes (49.1%) at follow-up. Progression of macular thinning was observed in 25.5% (27/106) of the eyes and sickle cell retinopathy progression in 15.1% (16/106) of the eyes. Predictors for the progression of macular thinning were proliferative retinopathy (adjusted odds ratio 3.40, P = 0.024), lower vessel density in the superior capillary plexus of the inferior parafoveal subfield (adjusted odds ratio 0.88, P = 0.003), and higher vessel density in the deep capillary plexus of the inferior parafoveal subfield (adjusted odds ratio 1.17, P = 0.001). No association was found between the progression of macular thinning and the worsening of other organ damage, sickle cell retinopathy progression, ocular complications, or laser treatment. CONCLUSION: Sickle cell disease-related maculopathy progresses in many patients without impairing visual acuity during short-term follow-up. Progression of maculopathy is correlated with proliferative retinopathy and vessel densities in inferior parafoveal subfields. Further research is needed to elucidate functional consequences of macular changes.

来源:Retina,查看原文。版权归原作者所有。

引用

  1. Brandsen RP, Biemond BJ, Nur E, et al. LONGITUDINAL CHANGES OF MACULAR NEURODEGENERATIVE AND VASCULAR ABNORMALITIES ON OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN SICKLE CELL DISEASE. Retina. 2025. PMID: 40262143. doi:10.1097/IAE.0000000000004393

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。